eMS News

Dr. John Corboy, Co-Director of the Rocky Mountain MS Center at University of Colorado, has been named the inaugural Charles Elliot Morris Chair in Neurology. Dr. Corboy serves as Co-Director…

The US Food and Drug Administration (FDA) has approved oral cladribine (brand named Mavenclad®, EMD Serono) for the treatment of adults with relapsing forms of MS, including relapsing-remitting MS and…

The US Food and Drug Administration (FDA) has approved oral Siponimod (brand named Mayzent®, Novartis International AG) to treat clinically isolated syndrome (an initial neurological episode), relapsing forms of MS,…

Meet Madison Tran and Daren Writer — part of the team behind “Jags Against MS.” The students at Rock Canyon High School in Highlands Ranch, home of the Jaguars, have…